Cargando…

Metabolic profiling and novel plasma biomarkers for predicting survival in epithelial ovarian cancer

Epithelial ovarian cancer (EOC) is one of the most lethal gynecological malignancies around the world, and patients with ovarian cancer always have an extremely poor chance of survival. Therefore, it is meaningful to develop a highly efficient model that can predict the overall survival for EOC. In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Hongyu, Hou, Yan, Cheng, Jinlong, Openkova, Margarita S., Xia, Bairong, Wang, Wenjie, Li, Ang, Yang, Kai, Li, Junnan, Xu, Huan, Yang, Chunyan, Ma, Libing, Li, Zhenzi, Fan, Xin, Li, Kang, Lou, Ge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458273/ https://www.ncbi.nlm.nih.gov/pubmed/28389631 http://dx.doi.org/10.18632/oncotarget.16739

Ejemplares similares

Distinct plasma lipids profiles of recurrent ovarian cancer by liquid chromatography-mass spectrometry
por: Li, Junnan, et al.
Publicado: (2016)

A Comprehensive Analysis of Metabolomics and Transcriptomics in Cervical Cancer
por: Yang, Kai, et al.
Publicado: (2017)

Identification of a six-lncRNA signature associated with recurrence of ovarian cancer
por: Yang, Kai, et al.
Publicado: (2017)

Erratum: Identification of a six-lncRNA signature associated with recurrence of ovarian cancer
por: Yang, Kai, et al.
Publicado: (2017)

Metabolomics for biomarker discovery in the diagnosis, prognosis, survival and recurrence of colorectal cancer: a systematic review
por: Zhang, Fan, et al.
Publicado: (2017)

Identifying Potential Markers for Monitoring Progression to Ovarian Cancer Using Plasma Label-free Proteomics
por: Wang, Wenjie, et al.
Publicado: (2021)

Metabolic phenotyping for monitoring ovarian cancer patients
por: Ke, Chaofu, et al.
Publicado: (2016)

miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6
por: Xia, Bairong, et al.
Publicado: (2015)

KIAA0101, a target gene of miR-429, enhances migration and chemoresistance of epithelial ovarian cancer cells
por: Chen, Hong, et al.
Publicado: (2016)

Use of Plasma Metabolomics to Identify Diagnostic Biomarkers for Early Stage Epithelial Ovarian Cancer
por: Fan, Lijun, et al.
Publicado: (2016)

An Immunophenotyping of Ovarian Cancer With Clinical and Immunological Significance
por: Yang, Kai, et al.
Publicado: (2018)

Targeting DNA Repair Response Promotes Immunotherapy in Ovarian Cancer: Rationale and Clinical Application
por: Xie, Hongyu, et al.
Publicado: (2021)

A Prognostic Nomogram for Cervical Cancer after Surgery from SEER Database
por: Wang, Ce, et al.
Publicado: (2018)

Long non-coding RNA ZFAS1 interacts with miR-150-5p to regulate Sp1 expression and ovarian cancer cell malignancy
por: Xia, Bairong, et al.
Publicado: (2017)

miR-338-3p suppresses tumor growth of ovarian epithelial carcinoma by targeting Runx2
por: Wen, Chunyan, et al.
Publicado: (2021)

Distal pancreatectomy with splenectomy for the management of splenic hilum metastasis in cytoreductive surgery of epithelial ovarian cancer
por: Xiang, Libing, et al.
Publicado: (2016)

Integrated analysis of a competing endogenous RNA network reveals an 11-lncRNA prognostic signature in ovarian cancer
por: Zhang, Yongjian, et al.
Publicado: (2020)

Stonin 2 Overexpression is Correlated with Unfavorable Prognosis and Tumor Invasion in Epithelial Ovarian Cancer
por: Sun, Xiaoying, et al.
Publicado: (2017)

Proteomics analysis to reveal biological pathways and predictive proteins in the survival of high-grade serous ovarian cancer
por: Xie, Hongyu, et al.
Publicado: (2017)

Single-Cell Sequencing of Malignant Ascites Reveals Transcriptomic Remodeling of the Tumor Microenvironment during the Progression of Epithelial Ovarian Cancer
por: Li, Yiqun, et al.
Publicado: (2022)

Prognostic significance of FA score based on plasma fibrinogen and serum albumin in patients with epithelial ovarian cancer
por: Li, Yuan, et al.
Publicado: (2019)

Period Analysis of Intraracial Differences in Incidence and Survival Rates in Epithelial Ovarian Cancer
por: Han, Lili, et al.
Publicado: (2021)

Prognostic Significance of CA125 Dynamic Change for Progression Free Survival in Patients with Epithelial Ovarian Carcinoma
por: Li, Zemin, et al.
Publicado: (2020)

Biomarker Assessment of Homologous Recombination Deficiency in Epithelial Ovarian Cancer: Association With Progression-Free Survival After Surgery
por: Yi, Huan, et al.
Publicado: (2022)

Mediation Analysis Reveals Potential Biological Mechanism of Ascites Influencing Recurrence in Patients with Epithelial Ovarian Cancer
por: Yang, Chunyan, et al.
Publicado: (2020)

Diurnal Cortisol and Survival in Epithelial Ovarian Cancer
por: Schrepf, Andrew, et al.
Publicado: (2015)

ZNF711 down-regulation promotes CISPLATIN resistance in epithelial ovarian cancer via interacting with JHDM2A and suppressing SLC31A1 expression
por: Wu, Geyan, et al.
Publicado: (2021)

Detection of human cytomegalovirus in patients with epithelial ovarian cancer and its impacts on survival
por: Yin, Min, et al.
Publicado: (2020)

NKX2-8 deletion-induced reprogramming of fatty acid metabolism confers chemoresistance in epithelial ovarian cancer
por: Zhu, Jinrong, et al.
Publicado: (2019)

Utility Of Plasma circBNC2 As A Diagnostic Biomarker In Epithelial Ovarian Cancer
por: Hu, Yingchao, et al.
Publicado: (2019)

Nomograms for predicting overall survival and cancer-specific survival in elderly patients with epithelial ovarian cancer
por: Cheng, Hao, et al.
Publicado: (2023)

Marital status and survival in epithelial ovarian cancer patients: a SEER-based study
por: Wang, Xinyu, et al.
Publicado: (2017)

Impact of diabetes mellitus on epithelial ovarian cancer survival
por: Akhavan, Setareh, et al.
Publicado: (2018)

Early-Stage epithelial ovarian cancer: Predictors of survival
por: Upadhyay, Avinash, et al.
Publicado: (2022)

Plasma level of peroxiredoxin 3 in patients with polycystic ovarian syndrome
por: Liu, Hou-Li, et al.
Publicado: (2019)

Prognostic significance of TM4SF1 and DDR1 expression in epithelial ovarian cancer
por: Huang, Zhijiong, et al.
Publicado: (2023)

Long term survival of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in advanced epithelial ovarian cancer
por: Zhang, Jue, et al.
Publicado: (2021)

Endometriosis is the independent prognostic factor for survival in Chinese patients with epithelial ovarian carcinoma
por: Ren, Tong, et al.
Publicado: (2017)

ABO Blood Type Has No Impact on Survival in Patients with Epithelial Ovarian Cancer
por: Wang, Ling, et al.
Publicado: (2018)

Identification of potential markers for differentiating epithelial ovarian cancer from ovarian low malignant potential tumors through integrated bioinformatics analysis
por: Hao, Wende, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dog0a5o5hhc9k9hh43eeolkl95